{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:39:04Z","timestamp":1790991544084,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003280.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T00:00:00Z","timestamp":1494201600000}}],"reference-count":182,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003280.pub5","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T11:36:58Z","timestamp":1494243418000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy"],"prefix":"10.1002","volume":"2019","author":[{"given":"Mohamed","family":"Mahdi-Rogers","sequence":"first","affiliation":[{"name":"King's College Hospital; Department of Neurology; Denmark Hill London UK SE5 9RS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Brassington","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery; Queen Square Centre for Neuromuscular Diseases; PO Box 114 London UK WC1N 3BG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela A","family":"Gunn","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery; MRC Centre for Neuromuscular Diseases; PO Box 114 London UK WC1N 3BG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A","family":"van Doorn","sequence":"additional","affiliation":[{"name":"Erasmus University Medical Center; Department of Neurology; PO Box 2040 Rotterdam Netherlands 3000 CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard AC","family":"Hughes","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery; MRC Centre for Neuromuscular Diseases; PO Box 114 London UK WC1N 3BG"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"issue":"8","key":"10.1002\/14651858.CD003280.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1212\/WNL.35.8.1173","article-title":"Combined azathioprine and prednisone in chronic inflammatory demyelinating polyneuropathy","volume":"35","author":"Dyck","year":"1985","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1212\/WNL.53.1.57","article-title":"Randomized trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"53","author":"Hadden","year":"1999","journal-title":"Neurology"},{"issue":"11 Suppl 1","key":"10.1002\/14651858.CD003280.pub5-BIB0003|cit3","first-page":"A369","article-title":"Efficacy of interferon beta-1a in patients chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"70","author":"Gorson","year":"2008","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0004|cit4","first-page":"170","article-title":"Efficacy of interferon beta1A in patients with chronic inflammatory demyelinating polyneuropathy (CIDP)","volume":"13","author":"Gorson","year":"2008","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"8","key":"10.1002\/14651858.CD003280.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.0b013e3181d1a862","article-title":"Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"74","author":"Hughes","year":"2010","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0006|cit6","unstructured":"EUCTR2005-003382-16-GB Pilot randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial). - RMC Trial apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2005-003382-16-GB"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0007|cit7","first-page":"176","article-title":"A pilot randomised controlled trial of methotrexate for CIDP: Lessons for future trials","volume":"13","author":"Mahdi-Rogers","year":"2008","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"issue":"Suppl s2","key":"10.1002\/14651858.CD003280.pub5-BIB0008|cit8","first-page":"116","article-title":"Randomised trial of methotrexate in CIDP (RMC) study: Did the measurement of strength prove to be a weakness?","volume":"14","author":"Pace","year":"2009","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"RMC trial Group Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study Lancet Neurology 2009 158 64","DOI":"10.1016\/S1474-4422(08)70299-0"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0010|cit10","unstructured":"NCT01757574 Alemtuzumab in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) clinicaltrials.gov\/show\/NCT01757574"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0011|cit11","unstructured":"NCT00962429 Lipoic acid to treat chronic inflammatory demyelinating polyneuropathy-a randomised, double-blind, placebo controlled pilot study clinicaltrials.gov\/show\/NCT00962429"},{"issue":"7","key":"10.1002\/14651858.CD003280.pub5-BIB0012|cit12","first-page":"649","article-title":"Clinical observation on treatment of 10 patients with chronic inflammatory demyelinating polyneuropathy by gullong tongluo capsule combined with prednisone","volume":"29","author":"Hu","year":"July 2009","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi (Chinese)"},{"issue":"Suppl","key":"10.1002\/14651858.CD003280.pub5-BIB0013|cit13","first-page":"Poster no: P6.1","article-title":"Fingolimid (FTY720) oral for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): study design of the phase 3 FORCIDP trial","volume":"82","author":"Hartung","year":"2014","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003280.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/j.jns.2013.07.1321","article-title":"Fingolimod (FTY720) oral for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Study design of the phase 3 FORCIDP trial","volume":"333","author":"Hughes","year":"2013","journal-title":"Journal of the Neurological Sciences"},{"issue":"Suppl s2","key":"10.1002\/14651858.CD003280.pub5-BIB0015|cit15","first-page":"S48","article-title":"Oral fingolimod (FTY720) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): Study design of the phase 3 FORCIDP trial","volume":"18","author":"Hughes","year":"2013","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0016|cit16","unstructured":"NCT01625182 Evaluate efficacy and safety of fingolimod 0.5 mg orally once daily versus placebo in chronic inflammatory demyelinating polyradiculoneuropathy patients clinicaltrials.gov\/show\/NCT01625182"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0017|cit17","unstructured":"NCT00278629 Hematopoetic stem cell transplantation in chronic inflammatory demyelinating polyneuropathy clinicaltrials.gov\/show\/NCT00278629"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0018|cit18","unstructured":"JPRN-UMIN000000674 Cyclosporin A (Neoral) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) requiring repetitive administration of high-dose intravenous immunoglobulin apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000000674"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0019|cit19","unstructured":"NCT012494505 Interest of Mycophenolate for CIDP Weaning (MYCOPID) clinicaltrials.gov\/ct2\/show\/NCT02494505"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"41","author":"Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","year":"1991","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0021|cit21","unstructured":"Ahlm\u00e9n J Andersen O Hallgren G Peilot B Positive effect of tacrolimus (FK 506) in a case of CIDP 3rd International Conference on New Trends in Clinical and Experimental Immunosuppression 1998 110"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0022|cit22","doi-asserted-by":"crossref","unstructured":"Ahmed Z Powell R Llewelyn G Anstey A Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF \u03b1 therapy for chronic plaque psoriasis BMJ Case Reports 2011 10.1136\/bcr.08.2011.4674","DOI":"10.1136\/bcr.08.2011.4674"},{"issue":"Suppl","key":"10.1002\/14651858.CD003280.pub5-BIB0023|cit23","first-page":"S5","article-title":"Nonmyeloablative autologous hematopoetic stem cell transplant for the treatment of CIDP: An interim report","volume":"18","author":"Allen","year":"2013","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/mus.21584","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists","volume":"41","author":"Alshekhlee","year":"2010","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/brain\/81.2.157","article-title":"Recurrent polyneuropathies and their corticosteroid treatment; with five-year observations of a placebo-controlled case treated with corticotrophin, cortisone, and prednisone","volume":"81","author":"Austin","year":"1958","journal-title":"Brain"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/jnnp.2007.128694","article-title":"Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP","volume":"79","author":"Axelson","year":"2008","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8","article-title":"Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy","volume":"21","author":"Barnett","year":"1998","journal-title":"Muscle & Nerve"},{"issue":"8","key":"10.1002\/14651858.CD003280.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1001\/archneur.1989.00520440064022","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria","volume":"46","author":"Barohn","year":"1989","journal-title":"Archives of Neurology"},{"issue":"s1","key":"10.1002\/14651858.CD003280.pub5-BIB0029|cit29","first-page":"7","article-title":"Autologous stem cell transplantation of a patient with chronic demyelinating neuropathy and persistent conduction block","volume":"12","author":"Barreira","year":"2007","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"issue":"8604","key":"10.1002\/14651858.CD003280.pub5-BIB0030|cit30","first-page":"179","article-title":"Double-masked trial of azathioprine in multiple sclerosis","volume":"2","author":"British and Dutch Multiple Sclerosis Azathioprine Trial Group","year":"1988","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/jnnp.2009.177576","article-title":"Chronic inflammatory demyelinating polyneuropathy responsive to mycophenolate mofetil therapy","volume":"81","author":"Bedi","year":"2010","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/mus.20024","article-title":"Mycophenolate mofetil in dysimmune neuropathies: a preliminary study","volume":"29","author":"Benedetti","year":"2004","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Benedetti L Franciotta D Beronio A Cadenotti L Gobbi M Mancardi GL Rituximab efficacy in CIDP associated with idiopathic thrombocytopenic purpura Muscle & Nerve 2008 1076 7","DOI":"10.1002\/mus.21073"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.2009.188912","article-title":"Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature","volume":"82","author":"Benedetti","year":"2011","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0035|cit35","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"September 2014"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1474-7766.2005.00328.x","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy responding to rituximab","volume":"5","author":"Bodley-Scott","year":"2005","journal-title":"Practical Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.52.3.498","article-title":"Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy","volume":"52","author":"Bouchard","year":"1999","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD003280.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1212\/WNL.58.12.1856","article-title":"High-dose cyclophosphamide without stem-cell rescue for refractory CIDP","volume":"58","author":"Brannagan","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003280.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1468-1331.2004.00911.x","article-title":"Rituximab-responsive CIDP","volume":"11","author":"Briani","year":"2004","journal-title":"European Journal of Neurology"},{"issue":"Suppl","key":"10.1002\/14651858.CD003280.pub5-BIB0040|cit40","first-page":"S17","article-title":"Multicentre, randomised, open-label trial to compare efficacy and tolerance of corticosteroids and IVIg in patients with CIDP on a one-year follow-up","volume":"18","author":"Camdessanch\u00e9","year":"2013","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/WNL.56.1.94","article-title":"Mycophenolate mofetil: a safe and promising immunosuppressant in neuromuscular diseases","volume":"56","author":"Chaudhry","year":"2001","journal-title":"Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD003280.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0022-510X(03)00010-8","article-title":"Etanercept (Enbrel) therapy for chronic inflammatory demyelinating polyneuropathy","volume":"210","author":"Chin","year":"2003","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"Chi\u00f2 A Cocito D Bottacchi E Buffa C Leone M Plano F Idiopathic chronic inflammatory demyelinating polyneuropathy: an epidemiological study in Italy Journal of Neurology, Neurosurgery, and Psychiatry 2007 1349 53","DOI":"10.1136\/jnnp.2007.114868"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/BF00919601","article-title":"Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"242","author":"Choudhary","year":"1995","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0045|cit45","unstructured":"Cochrane Editorial Unit Cochrane Editorial and Publishing Resource (updated May 2015) (community.cochrane.org\/editorial-and-publishing-policy-resource)"},{"issue":"12","key":"10.1002\/14651858.CD003280.pub5-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1468-1331.2011.03495.x","article-title":"Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis","volume":"18","author":"Cocito","year":"2011","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/WNL.46.6.1607","article-title":"Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study","volume":"46","author":"Confavreux","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ejpn.2011.08.002","article-title":"Rituximab in a childhood-onset idiopathic refractory chronic inflammatory demyelinating polyneuropathy","volume":"16","author":"D'Amico","year":"2012","journal-title":"European Journal of Paediatric Neurology: EJPN"},{"issue":"Suppl","key":"10.1002\/14651858.CD003280.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ana.410090719","article-title":"Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment","volume":"9","author":"Dalakas","year":"1981","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Dalakas MC Rakocevic G Salajegheh M Dambrosia JM Hahn AF Raju R Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy Annals of Neurology 2009 286 93","DOI":"10.1002\/ana.21577"},{"issue":"23","key":"10.1002\/14651858.CD003280.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1212\/WNL.0000000000001044","article-title":"Changing outcome in inflammatory neuropathies: Rasch-comparative responsiveness","volume":"83","author":"Draak","year":"2014","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003280.pub5-BIB0052|cit52","first-page":"621","article-title":"Chronic inflammatory polyradiculoneuropathy","volume":"50","author":"Dyck","year":"1975","journal-title":"Mayo Clinic Proceedings"},{"issue":"8","key":"10.1002\/14651858.CD003280.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198602203140801","article-title":"Plasma exchange in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"314","author":"Dyck","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"36","author":"Dyck","year":"1994","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/B978-0-7216-9491-7.50043-0","article-title":"Quantitating overall neuropathic symptoms, impairments, and outcomes","volume-title":"Peripheral Neuropathy","author":"Dyck","year":"2005"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.21171","article-title":"Response to methotrexate in a chronic inflammatory demyelinating polyradiculoneuropathy patient","volume":"39","author":"D\u00edaz-Manera","year":"2009","journal-title":"Muscle & Nerve"},{"issue":"7","key":"10.1002\/14651858.CD003280.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/jnnp-2012-302374","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study","volume":"83","author":"Echaniz-Laguna","year":"2012","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1085-9489.2005.10302.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society","volume":"10","author":"Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society","year":"2005","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0059|cit59","unstructured":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society Journal of the Peripheral Nervous System : JPNS 2006 1 8"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0060|cit60","doi-asserted-by":"crossref","unstructured":"Van den Bergh PY Hadden RD Bouche P Cornblath DR Hahn A Illa I European Federation of Neurological Societies Peripheral Nerve Society European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision Journal of the Peripheral Nervous System : JPNS 2010 356 63","DOI":"10.1111\/j.1468-1331.2009.02930.x"},{"issue":"12","key":"10.1002\/14651858.CD003280.pub5-BIB0061|cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001797.pub3","article-title":"Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Eftimov","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nmd.2005.01.005","article-title":"129th ENMC International Workshop: Clinical Trials for Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy, 27th October 2004, Schiphol airport, The Netherlands","volume":"15","author":"Hughes RAC on behalf of the CIDP and MMN Trial Group","year":"2005","journal-title":"Neuromuscular Disorders : NMD"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/mus.24311","article-title":"Remission with fingolimod in a case of demyelinating polyneuropathy","volume":"50","author":"Erdener","year":"2014","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Fialho D Chan YC Allen DC Reilly MM Hughes RA Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate Journal of Neurology, Neurosurgery, and Psychiatry 2006 544 7","DOI":"10.1136\/jnnp.2005.074781"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1085-9489.2005.10104.x","article-title":"High-dose cyclophosphamide results in long-term disease remission with restoration of a normal quality of life in patients with severe refractory chronic inflammatory demyelinating polyneuropathy","volume":"10","author":"Gladstone","year":"2005","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1212\/WNL.51.6.1735","article-title":"Pulse cyclophosphamide therapy in chronic inflammatory demyelinating polyneuropathy","volume":"51","author":"Good","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1212\/WNL.48.3.777","article-title":"Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1212\/01.WNL.0000134676.05850.C0","article-title":"Efficacy of mycophenolate mofetil in patients with chronic immune demyelinating polyneuropathy","volume":"63","author":"Gorson","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mus.20664","article-title":"Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial","volume":"35","author":"Gorson","year":"2007","journal-title":"Muscle & Nerve"},{"issue":"8","key":"10.1002\/14651858.CD003280.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/jnnp.2005.081547","article-title":"A modified peripheral neuropathy scale: the Overall Neuropathy Limitations Scale","volume":"77","author":"Graham","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"Pt 4","key":"10.1002\/14651858.CD003280.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"issue":"Pt 4","key":"10.1002\/14651858.CD003280.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/brain\/119.4.1067","article-title":"Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double-blind placebo-controlled cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/B978-0-7216-9491-7.50102-2","article-title":"Chronic Inflammatory Demyelinating Polyradiculoneuropathy","volume-title":"Peripheral Neuropathy","volume":"2","author":"Hahn","year":"2005"},{"issue":"12","key":"10.1002\/14651858.CD003280.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0035-3787(07)78408-4","article-title":"Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature","volume":"163","author":"Hamon","year":"2007","journal-title":"Revue Neurologique"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/BF00314752","article-title":"Treatment of chronic relapsing inflammatory demyelinating polyneuropathy by cyclosporin A and plasma exchange. A case report","volume":"237","author":"Hefter","year":"1990","journal-title":"Journal of Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0076|cit76","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/jnnp.2005.076869","article-title":"Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H)","volume":"77","author":"Hirst","year":"2006","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jnnp.53.4.327","article-title":"Cyclosporin A in the treatment of chronic demyelinating polyradiculoneuropathy","volume":"53","author":"Hodgkinson","year":"1990","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0079|cit79","doi-asserted-by":"crossref","unstructured":"Holman R Lindeboom R Vermeulen M de Haan RJ The AMC Linear Disability Score project in a population requiring residential care: psychometric properties Health and Quality of Life Outcomes 2004 42","DOI":"10.1186\/1477-7525-2-42"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/archneur.1992.00530300044009","article-title":"Subacute idiopathic demyelinating polyradiculoneuropathy","volume":"49","author":"Hughes","year":"1992","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/ana.1088","article-title":"Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Hughes","year":"2001","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0082|cit82","doi-asserted-by":"crossref","unstructured":"Hughes RA Donofrio P Bril V Dalakas MC Deng C Hanna K ICE Study Group Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE Study): a randomised placebo-controlled trial Lancet Neurology 2008 136 44","DOI":"10.1016\/S1474-4422(07)70329-0"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002062.pub3","article-title":"Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Hughes","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD003280.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1177\/0961203312440346","article-title":"Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide. [Review]","volume":"21","author":"Jasmin","year":"2012","journal-title":"Lupus"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ajh.10079","article-title":"EBV-associated lymphoma and chronic inflammatory demyelinating polyneuropathy in an adult without overt immunodeficiency","volume":"69","author":"Kasamon","year":"2002","journal-title":"American Journal of Hematology"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetric neuropathy","volume":"54","author":"Katz","year":"2000","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003280.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"The prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0088|cit88","doi-asserted-by":"crossref","unstructured":"Kempen JH Daniel E Dunn JP Foster CS Gangaputra S Hanish A Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study BMJ 2009 b2480","DOI":"10.1136\/bmj.b2480"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1080\/14786410500441664","article-title":"Rituximab therapy in monoclonal IgM-related neuropathies","volume":"47","author":"Kilidireas","year":"2006","journal-title":"Leukemia and Lymphoma"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1212\/WNL.36.1.35","article-title":"Azathioprine toxicity in neuromuscular disease","volume":"36","author":"Kissel","year":"1986","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003280.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11910-015-0563-z","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy","volume":"15","author":"Kleyman","year":"2015","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1212\/01.WNL.0000134606.50529.C7","article-title":"Sustained remission of CIDP associated with Evans syndrome","volume":"63","author":"Knecht","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1212\/WNL.37.1.147","article-title":"Chronic nephrotoxicity complicating cyclosporin treatment of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"37","author":"Kolkin","year":"1987","journal-title":"Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD003280.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.11.015","article-title":"Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy","volume":"277","author":"Koski","year":"2009","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0095|cit95","doi-asserted-by":"crossref","unstructured":"Kuitwaard K van Koningsveld R Ruts L Jacobs BC van Doorn PA Recurrent Guillain-Barr\u00e9 syndrome Journal of Neurology, Neurosurgery, and Psychiatry 2009 56 9","DOI":"10.1136\/jnnp.2008.156463"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1212\/WNL.53.6.1364","article-title":"Interferon-beta 1a in chronic inflammatory demyelinating polyneuropathy","volume":"53","author":"Kuntzer","year":"1999","journal-title":"Neurology"},{"issue":"13","key":"10.1002\/14651858.CD003280.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"K\u00f6ller","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0098|cit98","doi-asserted-by":"crossref","unstructured":"Laughlin RS Dyck PJ Melton LJ 3rd Leibson C Ransom J Dyck PJ Incidence and prevalence of CIDP and the association of diabetes mellitus Neurology 2009 39 45","DOI":"10.1212\/WNL.0b013e3181aaea47"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CND.0000000000000083","article-title":"Fludarabine in the treatment of refractory chronic inflammatory demyelinating neuropathies","volume":"17","author":"Leitch","year":"2015","journal-title":"Journal of Clinical Neuromuscular Disease"},{"issue":"9","key":"10.1002\/14651858.CD003280.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.32.9.958","article-title":"Multifocal demyelinating neuropathy with persistent conduction block","volume":"32","author":"Lewis","year":"1982","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0101|cit101","unstructured":"Llewelyn JG Reilly MM Krishnan AV Doran M Ryan A Robertson NP Alemtuzumab in the treatment of IVIg-dependent chronic inflammatory demyelinating polyneuropathy Journal of the Peripheral Nervous System 2009 90 1 10.1111\/j.1529-8027.2009.00212.x"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/archneurol.2009.11","article-title":"Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-blocker therapy","volume":"66","author":"Lozeron","year":"2009","journal-title":"Archives of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England","volume":"66","author":"Lunn","year":"1999","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0104|cit104","unstructured":"Lunn MPT Rituximab usage in CIDP: A retrospective e-mail based data collection Journal of the Peripheral Nervous System : JPNS 2009 92 10.1111\/j.1529-8027.2009.00212.x"},{"issue":"10","key":"10.1002\/14651858.CD003280.pub5-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002827.pub4","article-title":"Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies","author":"Lunn","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1517\/14656566.6.4.569","article-title":"A review of the medical management of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"6","author":"L\u00e9ger","year":"2005","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"24","key":"10.1002\/14651858.CD003280.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1212\/WNL.0b013e318296e92b","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathy","volume":"80","author":"L\u00e9ger","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1136\/jnnp.60.2.185","article-title":"Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A","volume":"60","author":"Mahattanakul","year":"1996","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"s1","key":"10.1002\/14651858.CD003280.pub5-BIB0109|cit109","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1529-8027.2007.00123.x","article-title":"Autologous peripheral blood progenitor cell transplantation for Chronic inflammatory demyelinating polyradiculoneuropathy","volume":"12","author":"Mahdi-Rogers","year":"2007","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0110|cit110","unstructured":"Mahdi-Rogers M Al-Chalabi A Hughes RAC Prevalence and morbidity of chronic inflammatory neuropathies in South East England Journal of the Peripheral Nervous System : JPNS 2008 176 7 10.1111\/j.1529-8027.2008.00174.x"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0111|cit111","doi-asserted-by":"crossref","unstructured":"Mahdi-Rogers M Kazmi M Ferner R Hughes RA Renaud S Steck AJ Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy Journal of the Peripheral Nervous System : JPNS 2009 118 24","DOI":"10.1111\/j.1529-8027.2009.00221.x"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/ene.12190","article-title":"Epidemiology of chronic inflammatory neuropathies in southeast England","volume":"21","author":"Mahdi-Rogers","year":"2014","journal-title":"European Journal of Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/ene.12080","article-title":"Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"20","author":"Markvardsen","year":"2013","journal-title":"European Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00415-009-5437-3","article-title":"Alemtuzumab in the treatment of IVIG-dependent chronic inflammatory demyelinating polyneuropathy","volume":"257","author":"Marsh","year":"2010","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1136\/jnnp.66.2.197","article-title":"Chronic motor neuropathies: response to interferon-beta 1a after failure of conventional therapies","volume":"66","author":"Martina","year":"1999","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jnnp.65.4.604","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy during treatment with interferon-alpha","volume":"65","author":"Marzo","year":"1998","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD003280.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2004.05.014","article-title":"Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy","volume":"224","author":"Matsuda","year":"2004","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2169\/internalmedicine.44.68","article-title":"Exacerbation of chronic inflammatory demyelinating polyradiculoneuropathy during interferon beta-1b therapy in a patient with childhood-onset multiple sclerosis","volume":"44","author":"Matsuse","year":"2005","journal-title":"Internal Medicine (Tokyo, Japan)"},{"issue":"Pt 6","key":"10.1002\/14651858.CD003280.pub5-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/brain\/110.6.1617","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases","volume":"110","author":"McCombe","year":"1987","journal-title":"Brain"},{"issue":"8","key":"10.1002\/14651858.CD003280.pub5-BIB0120|cit120","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003906.pub4","article-title":"Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mehndiratta","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cei.12195","article-title":"Disease-modifying therapy in multiple sclerosis and chronic inflammatory demyelinating polyradiculoneuropathy: common and divergent current and future strategies. [Review]","volume":"175","author":"Melzer","year":"2014","journal-title":"Clinical and Experimental Immunology"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","article-title":"Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy","volume":"56","author":"Mendell","year":"2001","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1097-4598(200003)23:3<433::AID-MUS17>3.0.CO;2-O","article-title":"Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha","volume":"23","author":"Meriggioli","year":"2000","journal-title":"Muscle & Nerve"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.72.5.596","article-title":"Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies","volume":"72","author":"Merkies","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1568008043339947","article-title":"Treatment of inflammatory and paraproteinemic neuropathies","volume":"4","author":"Monaco","year":"2004","journal-title":"Current Drug Targets. Immune, Endocrine and Metabolic Disorders"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-510X(01)00478-6","article-title":"Mycophenolate (CellCept) treatment of myasthenia gravis, chronic inflammatory polyneuropathy and inclusion body myositis","volume":"185","author":"Mowzoon","year":"2001","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0127|cit127","doi-asserted-by":"crossref","unstructured":"Mygland A Monstad P Chronic polyneuropathies in Vest-Agder, Norway European Journal of Neurology 2001 157 65","DOI":"10.1046\/j.1468-1331.2001.00187.x"},{"issue":"1-2","key":"10.1002\/14651858.CD003280.pub5-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jns.2007.02.027","article-title":"Rituximab in chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus","volume":"256","author":"M\u00fcnch","year":"2007","journal-title":"Journal of the Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00415-005-0805-0","article-title":"Treatment of dys-immune neuropathies","volume":"252","author":"Nobile-Orazio","year":"2005","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1474-4422(12)70093-5","article-title":"Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial","volume":"11","author":"Nobile-Orazio","year":"2012","journal-title":"Lancet Neurology"},{"issue":"8","key":"10.1002\/14651858.CD003280.pub5-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/jnnp.2003.035428","article-title":"Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin","volume":"76","author":"Odaka","year":"2005","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD003280.pub5-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.55.8.677","article-title":"'Chronic sensory demyelinating neuropathy': chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy","volume":"55","author":"Oh","year":"1992","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD003280.pub5-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1212\/01.WNL.0000096166.28131.4C","article-title":"Subacute inflammatory demyelinating polyneuropathy","volume":"61","author":"Oh","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD003280.pub5-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/jnnp.53.9.789","article-title":"Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study","volume":"53","author":"Ormerod","year":"1990","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"18","key":"10.1002\/14651858.CD003280.pub5-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1212\/01.wnl.0000277266.53449.8b","article-title":"Nonmyeloablative autologous hematopoietic stem cell transplantation for refractory CIDP","volume":"69","author":"Oyama","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1212\/WNL.50.6.1778","article-title":"A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group","volume":"50","author":"Palace","year":"1998","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00415-002-0693-5","article-title":"Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy","volume":"249","author":"Pavesi","year":"2002","journal-title":"Journal of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/jnnp-2013-306014","article-title":"Autologous haematopoietic stem cell transplantation: A viable treatment option for CIDP","volume":"85","author":"Press","year":"2014","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(76)90213-6","article-title":"Chronic relapsing polyneuritis","volume":"27","author":"Prineas","year":"1976","journal-title":"Journal of the Neurological Sciences"},{"issue":"9139","key":"10.1002\/14651858.CD003280.pub5-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised, double-blind, placebo-controlled study of interferon-beta 1a in relapsing-remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","volume":"352","author":"PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group","year":"1998","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD003280.pub5-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.56.12.1628","article-title":"PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS","volume":"56","author":"PRISMS Study Group and the University of British Columbia MS\/MRI Analysis Group","year":"2001","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0142|cit142","first-page":"273","article-title":"Long term follow up in chronic inflammatory demyelinating polyneuropathy (CIDP) under interferon beta-1a (IFN-b1a) and intravenous immunoglobulin (IVIg)","volume":"70","author":"Radziwill","year":"2001","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0143|cit143","doi-asserted-by":"crossref","unstructured":"Radziwill AJ Schweikert K Kuntzer Fuhr P Steck AJ Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open label study European Journal of Neurology 2006 37 8","DOI":"10.1159\/000095139"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0144|cit144","doi-asserted-by":"crossref","unstructured":"Rem\u00e9nyi P Masszi T Borb\u00e9nyi Z So\u00f3s J Sikl\u00f3s L Englelhardt JI CIDP cured by allogeneic hematopoietic stem cell transplantation European Journal of Neurology 2007 e1-e2","DOI":"10.1111\/j.1468-1331.2007.01615.x"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0145|cit145","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Reference Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0146|cit146","first-page":"510","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy refractory to multiple treatment modalities responds to rituximab","volume":"134","author":"Rose","year":"2010","journal-title":"American Journal of Clinical Pathology"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1212\/01.wnl.0000167549.09664.b8","article-title":"Distinguishing acute-onset CIDP from Guillain-Barr\u00e9 syndrome with treatment related fluctuations","volume":"65","author":"Ruts","year":"2005","journal-title":"Neurology"},{"issue":"21","key":"10.1002\/14651858.CD003280.pub5-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1212\/WNL.0b013e3181e07d14","article-title":"Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study","volume":"74","author":"Ruts","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0960-8966(00)00119-X","article-title":"Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome","volume":"10","author":"Ryan","year":"2000","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/jnnp.2009.174888","article-title":"Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis","volume":"82","author":"Sadnicka","year":"2011","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD003280.pub5-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1007\/s00296-011-2130-5","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy in a patient with systemic lupus erythematosus and good outcome with rituximab treatment","volume":"32","author":"Sanz","year":"2012","journal-title":"Rheumatology International"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0152|cit152","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/(SICI)1097-4598(199905)22:5<560::AID-MUS2>3.0.CO;2-Q","article-title":"Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome","volume":"22","author":"Saperstein","year":"1999","journal-title":"Muscle & Nerve"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1055\/s-2008-1062268","article-title":"Chronic acquired demyelinating polyneuropathies","volume":"28","author":"Saperstein","year":"2008","journal-title":"Seminars in Neurology"},{"issue":"Pt 2","key":"10.1002\/14651858.CD003280.pub5-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/brain\/118.2.359","article-title":"Long-term follow-up of patient with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy","volume":"118","author":"Simmons","year":"1995","journal-title":"Brain"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0156|cit156","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005376.pub3","article-title":"Treatment for IgG and IgA paraproteinaemic neuropathy","author":"Stork","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1-2","key":"10.1002\/14651858.CD003280.pub5-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2013.01.003","article-title":"A review of the use of biological agents for chronic inflammatory demyelinating polyradiculoneuropathy","volume":"326","author":"St\u00fcbgen","year":"2013","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5692\/clinicalneurol.52.172","article-title":"[Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels]. [Japanese]","volume":"52","author":"Takeuchi","year":"2012","journal-title":"Rinsho Shinkeigaku [Clinical Neurology]"},{"issue":"Pt 3","key":"10.1002\/14651858.CD003280.pub5-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/119.3.765","article-title":"Focal upper limb demyelinating neuropathy","volume":"119","author":"Thomas","year":"1996","journal-title":"Brain"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0160|cit160","doi-asserted-by":"crossref","unstructured":"Thompson N Choudhary P Hughes RA Quinlivan RM A novel trial design to study the effect of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy Journal of Neurology 1996 280 5","DOI":"10.1007\/BF00868527"},{"issue":"6","key":"10.1002\/14651858.CD003280.pub5-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1468-1331.2002.00478.x","article-title":"Mycophenolate in treatment-resistant inflammatory neuropathies","volume":"9","author":"Umapathi","year":"2002","journal-title":"European Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0162|cit162","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003217.pub5","article-title":"Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy","author":"Umapathi","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8 Suppl 3","key":"10.1002\/14651858.CD003280.pub5-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1212\/WNL.60.8_suppl_3.S23","article-title":"Interferon beta-1a as an investigational treatment for CIDP","volume":"60","author":"Vallat","year":"2003","journal-title":"Neurology"},{"issue":"5-6","key":"10.1002\/14651858.CD003280.pub5-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1159\/000381767","article-title":"Natalizumab as a disease-modifying therapy in chronic inflammatory demyelinating polyneuropathy - a report of three cases","volume":"73","author":"Vallat","year":"2015","journal-title":"European Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1468-1331.2009.02930.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision","volume":"17","author":"Bergh","year":"2010","journal-title":"European Journal of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003280.pub5-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1085-9489.2005.0010203.x","article-title":"Treatment of Guillain-Barr\u00e9 syndrome and CIDP","volume":"10","author":"Doorn","year":"2005","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1212\/WNL.0b013e318208824b","article-title":"Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies","volume":"76","author":"Nes","year":"2011","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD003280.pub5-BIB0168|cit168","first-page":"245-53","article-title":"Pulsed high-dose dexamethasone versus standard prednisolone treatment for chronic inflammatory demyelinating polyradiculoneuropathy (PREDICT study): a double-blind, randomised, controlled trial","volume":"9","author":"Schaik","year":"2010","journal-title":"Lancet Neurology"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD003280.pub5-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1468-1331.2012.03851.x","article-title":"Vigorimeter grip strength in CIDP: a responsive tool that rapidly measures the effect of IVIG - the ICE study","volume":"20","author":"Vanhoutte","year":"2013","journal-title":"European Journal of Neurology"},{"issue":"s1","key":"10.1002\/14651858.CD003280.pub5-BIB0171|cit171","first-page":"S34","article-title":"Rituximab in two cases of chronic inflammatory demyelinating polyradiculoneuropathy not responsive to other treatments","volume":"19","author":"Velardo","year":"2014","journal-title":"Journal of the Peripheral Nervous System : JPNS"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp.56.1.36","article-title":"Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: A double blind, placebo controlled study","volume":"56","author":"Vermeulen","year":"1993","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1136\/jnnp.72.1.127","article-title":"Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"72","author":"Vermeulen","year":"2002","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD003280.pub5-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/jnnp.2007.118240","article-title":"Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation","volume":"78","author":"Vermeulen","year":"2007","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"10.1002\/14651858.CD003280.pub5-BIB0175|cit175","doi-asserted-by":"crossref","unstructured":"Viala K Reni\u00e9 L Maisonobe T B\u00e9hin A Neil J L\u00e9ger JM Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome Brain 2004 2010 7","DOI":"10.1093\/brain\/awh222"},{"issue":"7","key":"10.1002\/14651858.CD003280.pub5-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/BF00314898","article-title":"Focal cranial nerve involvement in chronic inflammatory demyelinating polyneuropathy: clinical and MRI evidence of peripheral and central lesions","volume":"236","author":"Waddy","year":"1989","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/0883073812471719","article-title":"Childhood chronic inflammatory demyelinating polyneuropathy: an overview of 10 cases in the modern era","volume":"29","author":"Ware","year":"2014","journal-title":"Journal of Child Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003280.pub5-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archneurol.2010.143","article-title":"Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"67","author":"Wolf","year":"2010","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1046\/j.1469-7580.2002.00041.x","article-title":"Systematic reviews of treatment for inflammatory demyelinating neuropathy","volume":"200","author":"Hughes","year":"2002","journal-title":"Journal of Anatomy"},{"issue":"1","key":"10.1002\/14651858.CD003280.pub5-BIB0180|cit180","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003280","article-title":"Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Hughes","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003280.pub5-BIB0181|cit181","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003280.pub2","article-title":"Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Hughes","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD003280.pub5-BIB0182|cit182","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003280.pub3","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy","author":"Mahdi-Rogers","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003280.pub5\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T05:49:33Z","timestamp":1660542573000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003280.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":182,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003280.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]}}}